Bachar Samra

853 total citations
18 papers, 364 citations indexed

About

Bachar Samra is a scholar working on Oncology, Hematology and Public Health, Environmental and Occupational Health. According to data from OpenAlex, Bachar Samra has authored 18 papers receiving a total of 364 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Oncology, 6 papers in Hematology and 5 papers in Public Health, Environmental and Occupational Health. Recurrent topics in Bachar Samra's work include Acute Lymphoblastic Leukemia research (5 papers), Chronic Lymphocytic Leukemia Research (3 papers) and Cancer Immunotherapy and Biomarkers (3 papers). Bachar Samra is often cited by papers focused on Acute Lymphoblastic Leukemia research (5 papers), Chronic Lymphocytic Leukemia Research (3 papers) and Cancer Immunotherapy and Biomarkers (3 papers). Bachar Samra collaborates with scholars based in United States, Lebanon and France. Bachar Samra's co-authors include Nicholas J. Short, Hagop M. Kantarjian, Elias Jabbour, Farhad Ravandi, Marina Konopleva, Naval Daver, Courtney D. DiNardo, Alessandro Isidori, Babak Baseri and Eric Tam and has published in prestigious journals such as SHILAP Revista de lepidopterología, Blood and Journal of Hematology & Oncology.

In The Last Decade

Bachar Samra

18 papers receiving 360 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Bachar Samra United States 9 150 136 113 97 58 18 364
George Yaghmour United States 12 143 1.0× 163 1.2× 104 0.9× 48 0.5× 34 0.6× 62 334
Ci Pan China 14 96 0.6× 107 0.8× 157 1.4× 70 0.7× 35 0.6× 37 405
Eun Sang Yi South Korea 11 98 0.7× 87 0.6× 110 1.0× 88 0.9× 32 0.6× 34 344
Olga Militano United States 12 247 1.6× 176 1.3× 134 1.2× 55 0.6× 27 0.5× 42 446
S Banavali India 10 139 0.9× 129 0.9× 244 2.2× 128 1.3× 39 0.7× 25 497
Fabio Guolo Italy 10 112 0.7× 127 0.9× 42 0.4× 78 0.8× 19 0.3× 46 306
Rayaz Ahmed India 12 286 1.9× 104 0.8× 110 1.0× 122 1.3× 18 0.3× 55 459
Susan R. Wiersma United States 13 260 1.7× 78 0.6× 175 1.5× 137 1.4× 38 0.7× 16 517
Mohamed Samra Egypt 10 109 0.7× 84 0.6× 40 0.4× 67 0.7× 19 0.3× 44 296
Satyajit Kosuri United States 12 247 1.6× 150 1.1× 73 0.6× 128 1.3× 50 0.9× 47 420

Countries citing papers authored by Bachar Samra

Since Specialization
Citations

This map shows the geographic impact of Bachar Samra's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Bachar Samra with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Bachar Samra more than expected).

Fields of papers citing papers by Bachar Samra

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Bachar Samra. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Bachar Samra. The network helps show where Bachar Samra may publish in the future.

Co-authorship network of co-authors of Bachar Samra

This figure shows the co-authorship network connecting the top 25 collaborators of Bachar Samra. A scholar is included among the top collaborators of Bachar Samra based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Bachar Samra. Bachar Samra is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

18 of 18 papers shown
1.
Samra, Bachar, Joseph D. Khoury, Kiyomi Morita, et al.. (2021). Long term outcome of Hyper-CVAD-R for Burkitt leukemia/lymphoma and high-grade B-cell lymphoma: focus on CNS relapse. Blood Advances. 5(20). 3913–3918. 12 indexed citations
2.
Assi, Tarek, Sarah Watson, Bachar Samra, et al.. (2021). Targeting the VEGF Pathway in Osteosarcoma. Cells. 10(5). 1240–1240. 42 indexed citations
3.
Samra, Bachar, Guillaume Richard‐Carpentier, Tapan M. Kadia, et al.. (2020). Characteristics and outcomes of patients with therapy-related acute myeloid leukemia with normal karyotype. Blood Cancer Journal. 10(5). 47–47. 17 indexed citations
4.
Samra, Bachar, Elias Jabbour, Farhad Ravandi, Hagop M. Kantarjian, & Nicholas J. Short. (2020). Evolving therapy of adult acute lymphoblastic leukemia: state-of-the-art treatment and future directions. Journal of Hematology & Oncology. 13(1). 70–70. 109 indexed citations
5.
Samra, Bachar, Hagop M. Kantarjian, Koji Sasaki, et al.. (2020). Discontinuation of Maintenance Tyrosine Kinase Inhibitors in Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia outside of Transplant. Acta Haematologica. 144(3). 285–292. 12 indexed citations
6.
Samra, Bachar, Marina Konopleva, Alessandro Isidori, Naval Daver, & Courtney D. DiNardo. (2020). Venetoclax-Based Combinations in Acute Myeloid Leukemia: Current Evidence and Future Directions. Frontiers in Oncology. 10. 562558–562558. 47 indexed citations
7.
Assi, Tarek, Bachar Samra, Laurent Dercle, et al.. (2020). Screening Strategies for COVID-19 in Patients With Hematologic Malignancies. Frontiers in Oncology. 10. 1267–1267. 8 indexed citations
8.
Rassy, Elie, et al.. (2020). Should we screen patients with hematologic malignancies for COVID ‐19?. Hematological Oncology. 38(5). 648–653. 1 indexed citations
9.
Samra, Bachar, Eric Tam, Babak Baseri, et al.. (2020). Clinical Characteristics and Outcomes of Caribbean Patients With Adult T-Cell Lymphoma/Leukemia at Two Affiliated New York City Hospitals. JCO Global Oncology. 6(6). 548–556. 3 indexed citations
10.
Baseri, Babak, et al.. (2019). An Exceptional Responder to Nivolumab in Metastatic Non-Small-Cell Lung Cancer: A Case Report and Literature Review of Long-Term Survivors. SHILAP Revista de lepidopterología. 2019. 1–7. 5 indexed citations
11.
Samra, Bachar, et al.. (2019). Doxorubicin‐associated takotsubo cardiomyopathy in a patient with adult T‐cell leukemia/lymphoma. SHILAP Revista de lepidopterología. 7(12). 2466–2471. 5 indexed citations
12.
Samra, Bachar, Hagop M. Kantarjian, Koji Sasaki, et al.. (2019). Discontinuation of Tyrosine Kinase Inhibitors (TKIs) in Philadelphia Chromosome-Positive (Ph+) Acute Lymphoblastic Leukemia (ALL). Blood. 134(Supplement_1). 3819–3819. 3 indexed citations
13.
Samra, Bachar, et al.. (2019). Screening Colonoscopy Unmasking Colonic Metastasis from an Occult Breast Ductal Carcinoma: A Case Report and Review of the Literature. SHILAP Revista de lepidopterología. 2019. 1–6. 3 indexed citations
14.
15.
Samra, Bachar, Eric Tam, Babak Baseri, & Iuliana Shapira. (2018). Checkpoint Inhibitors in Head and Neck Cancer: Current Knowledge and Perspectives. Journal of Investigative Medicine. 66(7). 1023–1030. 26 indexed citations
16.
Samra, Bachar, et al.. (2017). Primary Pulmonary Hodgkin's Lymphoma: A Rare Etiology of a Cavitary Lung Mass. Cureus. 9(8). e1620–e1620. 8 indexed citations
17.
Ibrahim, Uroosa, et al.. (2016). Anti–PD-1/PD-L1 antibodies in non-small cell lung cancer: the era of immunotherapy. Expert Review of Anticancer Therapy. 17(1). 47–59. 33 indexed citations
18.
Samra, Bachar, et al.. (2015). Idiopathic Hemophagocytic Lymphohistiocytosis during Pregnancy Treated with Steroids. Hematology Reports. 7(3). 6100–6100. 29 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026